SKIL vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 05, 2026

SKIL

53.3
AI Score
VS
UTI Wins

UTI

64.7
AI Score

Investment Advisor Scores

SKIL

53score
Recommendation
HOLD

UTI

65score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SKIL UTI Winner
Revenue 94.50M 661.15M UTI
Net Income -43.11M 15.54M UTI
Net Margin -45.6% 2.4% UTI
Operating Income -8.30M 19.27M UTI
ROE 59.2% 4.5% SKIL
ROA -5.1% 1.7% UTI
Total Assets 853.01M 897.86M UTI
Cash 115.56M 130.06M UTI
Debt/Equity -7.80 0.46 SKIL
Current Ratio 0.91 1.30 UTI
Free Cash Flow 28.52M -63.50M SKIL

Relative Price Performance (Last 90 Days)

SKIL 1M: -15.3% · 3M: -3.4% UTI 1M: -20.3% · 3M: -49.0%

Current Technical Phase

SKIL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $6.81

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.6%), weak momentum, RSI 32

RSI (14): 32.0 · Price: $22.20

Fundamentals Snapshot

Metric SKIL UTI
Market Cap
Forward P/E 1.5 30.2
Trailing P/E 34.3
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.7% 0.6%
Operating Margin -0.1% 0.0%
EPS -14.83 0.63
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.